AstraZeneca denies trial subject had a nervous ailment

AstraZeneca Plc, the drug maker working with the University of Oxford on a Covid-19 vaccine, contradicted a report that a volunteer in UK testing of the injection developed a rare nerve disease that could have pointed to serious safety concerns. . AstraZeneca responded to a CNN report on Thursday citing …

Read More »